Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06714552 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of a Sugar Replacement on Blood Glucose Levels in Healthy Adults

Study acronym: SURE-BloG
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Completed to Active, Not Recruiting
    • Study completion date: Apr 13, 2026 to Jul 31, 2026
    v7
  2. Primary completion date changed from estimate of Jul 2025 to Apr 13, 2026
    • Trial status: Recruiting to Completed
    • Study completion date changed from estimate of Oct 2025 to Apr 13, 2026
    • Site details revised
    v6
  3. Secondary endpoints: details revised at 3 of 6 entriesv5
  4. Eligibility criteria revisedv4
  5. Start date changed from estimate of Dec 20, 2024 to Jan 17, 2025v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Dec 2024 to Dec 20, 2024
    • Site details revised
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Diabetes and cardiovascular disease account for millions of deaths per year. One of the risk factors for both conditions is high blood sugar, particularly after eating (postprandial hyperglycaemia). Lowering blood sugar levels after a meal is expected to have a positive effect on preventing metabolic and cardiovascular diseases and improving the metabolic control of those who already suffer from these conditions. The aim of this study is to investigate the effect of Oligomate® (beta-galacto-oligosaccharide) on postprandial glycaemia when used as a partial replacement of glycaemic carbohydrates in a beverage in otherwise healthy volunteers. Volunteers will be given water with either Oligomate® or glucose (control) added. Blood samples will be collected at eight time points (two before drinking the beverage and six after) to measure glucose and insulin levels.
Trial Details
NCT Number NCT06714552
Lead Sponsor University of Aberdeen
Collaborators: Yakult Honsha Co., LTD
Conditions
(from sponsor)		 Postprandial Hyperglycemia, Hyperinsulinemia
Related terms Hyperglycemia, Hyperinsulinism
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov